crohn
diseas
cd
chronic
obstruct
pulmonari
diseas
copd
also
demonstr
proal
et
al
furthermor
appear
infect
polymicrobi
one
microb
act
synergist
sequenti
caus
infect
bakaletz
given
current
preval
signific
infecti
diseas
caus
bacteria
fungi
protist
virus
develop
world
comprehens
character
evolut
life
cycl
physiolog
versatil
metabol
pathogen
imper
genom
studi
genom
facilit
global
analysi
pathogen
huge
potenti
provid
invalu
insight
variou
facet
pathogenesi
genom
genomicsderiv
applic
use
studi
virul
transmiss
immun
evas
hostmicrobi
interact
microbi
ecolog
clinic
signifi
cant
pathogen
develop
world
virul
degre
pathogen
infecti
agent
indic
case
mortal
black
et
al
rate
abil
invad
damag
host
tissu
virul
mediat
sever
genet
factor
code
protein
involv
adhes
colon
toxin
product
invas
wholegenom
sequenc
use
conjunct
microarraybas
technolog
target
genet
screen
proteom
analysi
discov
virul
gene
recent
genom
use
develop
rapid
diagnost
tool
well
identifi
vaccin
drug
target
sever
bacteri
protozoan
viral
pathogen
could
adapt
resourcelimit
set
expans
genom
fuell
rapid
advanc
dnasequenc
technolog
sever
faster
cheaper
higher
throughput
nucleic
acid
sequenc
analysi
platform
becom
avail
last
year
access
ever
even
develop
countri
mani
describ
accompani
chapter
throughout
book
genom
tool
advantag
cultur
depend
pathogen
nucleic
acid
analys
long
cell
lost
viabil
henc
tool
invalu
resourcelimit
set
wherebi
reagent
equip
support
cultur
easili
access
eg
media
incub
freezer
better
understand
character
caus
morbid
essenti
achiev
millennium
develop
goal
mittelmark
reduc
childhood
mortal
chapter
focus
genom
tool
appli
understand
variou
aspect
human
infecti
diseas
develop
world
tool
could
appli
futur
studi
part
effort
control
treat
infecti
diseas
initi
focu
genom
applic
major
infecti
diseas
develop
world
ie
pneumonia
mening
malaria
tuberculosi
human
immunodefi
cienci
viru
hiv
diarrhoeal
diseas
fig
thereaft
pathogen
genom
neglect
tropic
diseas
ntd
discuss
focus
exampl
buruli
ulcer
trachoma
trypanosomiasi
nearli
fi
fth
eight
million
childhood
death
year
occur
worldwid
attribut
pneumonia
make
common
caus
death
among
children
rajaratnam
et
al
approxim
sever
pneumonia
case
develop
countri
attribut
streptococcu
pneumonia
haemophilu
infl
uenza
type
b
hib
area
vaccin
wide
avail
scott
english
likewis
two
pathogen
major
caus
nonepidem
mening
among
children
develop
world
neisseria
meningitidi
associ
epidem
particularli
africa
mening
belt
peltola
sever
pneumococc
virul
factor
known
long
time
fairli
well
character
polysaccharid
capsul
toxin
pneumolysin
pli
cholin
bind
protein
cbp
pilu
among
mani
other
mitchel
mitchel
recent
year
wholegenom
analysi
demonstr
pneumonia
harbour
sever
pathogen
island
genom
compar
genom
shown
virul
may
associ
singlenucleotid
polymorph
snp
absenc
genet
island
encod
virul
factor
pili
polysaccharid
capsul
compar
genom
noninvas
intermedi
virul
highli
virul
pneumonia
serotyp
show
eight
region
genom
larger
kb
uniqu
highli
virul
strain
among
identifi
ed
pathogen
island
encod
adher
factor
transport
metabol
enzym
preferenti
express
murin
lung
blood
compar
nasopharyng
tissu
harvey
et
al
wholegenom
sequenc
hypervirul
serotyp
isol
show
presenc
novel
kb
region
possibl
encod
bacteriophag
gene
enhanc
virul
thoma
et
al
although
streptococcu
miti
closest
rel
pneumonia
comparison
genom
show
miti
lack
cbp
hyaluronidas
gene
pli
import
virul
factor
pneumonia
denapait
et
al
strong
associ
chromosom
loci
increas
suscept
hib
diseas
among
alaskan
eskimo
children
demonstr
petersen
et
al
suggest
host
genom
could
import
determin
geograph
distribut
hib
invas
diseas
gramneg
bacilli
present
nasopharyng
mucosa
half
brazilian
angolan
children
sharp
contrast
dutch
children
surprisingli
gramneg
bacilli
common
caus
pneumonia
brazil
angola
mani
develop
countri
wolf
et
al
obaro
adegbola
specifi
calli
genet
background
ethnic
could
directli
associ
vulner
pneumonia
mening
invas
bacteri
diseas
instanc
arid
region
western
australia
pneumonia
moraxella
catarrhali
haemophilu
infl
uenza
carriag
severalfold
higher
among
aborigin
nonaborigin
children
refl
ect
larg
dispar
burden
pneumonia
mening
two
group
mackenzi
et
al
nasopharyng
carriag
respiratori
pathogen
among
chines
vietnames
children
year
hong
kong
signifi
cantli
differ
adjust
age
smoke
socioeconom
condit
henc
plausibl
hostgenom
studi
could
reveal
interest
associ
host
genet
vulner
variou
pathogen
warrant
attent
pathogen
transmit
across
individu
sever
mechan
includ
direct
physic
contact
ingest
contamin
materi
infect
bodi
fl
uid
secret
inhal
infect
air
droplet
vector
organ
zoonot
infect
transmit
direct
indirect
mechan
anim
host
bird
pig
bat
human
host
genom
applic
use
track
pathogen
transmit
across
individu
identifi
potenti
reservoir
within
popul
instanc
multilocu
sequenc
type
mlst
base
seven
housekeep
gene
pneumonia
isol
west
african
villag
household
show
strong
evid
nonrandom
distribut
pneumonia
sequenc
type
among
household
transmiss
often
occur
children
household
member
hill
et
al
surviv
prolifer
pathogen
establish
commun
compet
resourc
nutrient
growth
factor
brook
lysenko
et
al
within
environ
polymicrobi
immun
stimul
persist
microb
must
also
contend
host
multilay
defenc
constitut
barrag
bacteriostat
protein
bactericid
factor
secretori
immunoglobulin
mucociliari
clearanc
system
hand
microorgan
particularli
coevolv
human
host
develop
sever
strategi
evad
mucos
immun
respons
mucos
immun
respons
two
close
relat
oblig
colon
urt
mucosa
neisseria
lactamica
n
meningitidi
appear
distinct
contrast
pathogen
rel
n
lactamica
induc
develop
mucos
tand
bcell
young
individu
maintain
immunolog
ignor
host
may
facilit
longer
frequent
colon
observ
n
lactamica
strain
host
pathogen
genom
studi
could
appli
elucid
n
lactamica
prime
mucos
immun
system
vaughan
et
al
could
explain
fi
nding
compar
genom
hybrid
studi
variou
unrel
n
lactamica
strain
panneisseria
microarray
show
neisseria
virul
gene
absent
n
lactamica
genom
snyder
saunder
genomicsderiv
molecular
tool
use
accur
distinguish
phenotyp
morpholog
biochem
ident
pathogen
bedsid
effect
identifi
treat
infect
instanc
infant
admit
teach
hospit
gambia
primari
healthcar
facil
clinic
sign
indic
mening
pneumonia
serotyp
isol
cerebrospin
fl
uid
examin
csf
use
standard
laboratori
cultur
latex
agglutinationbas
serotyp
infect
treat
ceftriaxon
evid
neurolog
sequela
howev
within
day
infant
admit
medic
research
council
unit
pneumonia
serotyp
mening
despit
antibiot
treatment
administ
infant
suffer
neurolog
sequela
second
episod
initi
appear
case
endogen
reactiv
due
treatment
failur
fi
rst
episod
mening
howev
mlst
analysi
base
seven
pneumonia
housekeep
gene
conduct
two
serotyp
isol
reveal
belong
differ
unrel
sequenc
type
st
ie
common
gambia
fi
rst
episod
novel
st
belong
differ
clonal
complex
second
episod
henc
mlst
analysi
show
relaps
recurr
infect
microb
rather
exogen
differ
strain
infect
antonio
et
al
molecular
tool
advantag
cultur
depend
pathogen
nucleic
acid
analys
long
cell
lost
viabil
pneumococc
diseas
surveil
west
africa
region
pneumowar
consortium
csf
sampl
suspect
mening
case
cultur
neg
could
cultur
within
specifi
ed
time
character
speciesspecifi
c
serotypespecifi
c
pcr
mlst
genotyp
techniqu
may
also
use
character
pathogen
directli
csf
purifi
ed
nucleic
acid
facilit
identifi
cation
pneumonia
haemophilu
infl
uenza
type
b
n
meningitidi
cultureneg
csf
sampl
receiv
paediatr
bacteri
mening
network
pbm
data
gener
serv
evid
base
support
implement
lifesav
vaccin
among
govern
policymak
pharmaceut
donor
organ
tuberculosi
tb
previous
consid
control
infecti
diseas
univers
use
bacillu
bcg
vaccin
antibiot
treatment
howev
tb
current
repres
signifi
cant
reemerg
infecti
diseas
infect
third
world
popul
caus
two
million
death
annual
tb
caus
mycobacterium
tuberculosi
complex
includ
africanum
caus
tb
west
africa
reemerg
tb
partli
attribut
increas
incid
multidrugresist
mdr
tb
extens
drugresist
xdr
tb
import
factor
contribut
reemerg
tb
poor
protect
bcg
vaccin
region
hiv
coinfect
mycobacteria
genom
research
crucial
understand
evolut
adapt
pathogenesi
among
pathogen
caus
tb
develop
unambigu
type
tool
mycobacteria
genom
character
lack
horizont
gene
exchang
presenc
larg
sequenc
polymorph
lsp
snp
sever
irrevers
genom
delet
robust
phylogenet
inform
marker
use
defi
ning
lineag
within
mycobacteri
cluster
lspand
snpbase
phylogenet
studi
shown
distinct
geograph
pattern
distribut
tuberculosi
global
lineag
found
mani
differ
region
across
globe
other
restrict
certain
geograph
region
de
jong
et
al
lack
horizont
gene
transfer
mobil
genet
element
plasmid
suggest
drug
resist
mycobacteria
occur
spontan
chromosom
mutat
molecular
tool
use
identifi
sever
mutat
instanc
streptomycin
resist
associ
mutat
gene
encod
ribosom
protein
rrna
methyltransferas
gid
b
genotyp
analysi
shown
specifi
c
mutat
associ
specifi
c
lineag
instanc
one
studi
gid
b
polymorph
allel
exclus
found
latin
american
mediterranean
tuberculosi
genotyp
increas
burden
mdr
xdr
tb
develop
world
need
genom
research
mechan
drug
resist
transmiss
never
greater
spi
et
al
molecular
tool
also
adapt
rapid
diagnosi
infect
faster
standard
cultur
even
resourcelimit
set
sever
rapid
diagnost
system
develop
ie
accuprob
develop
genprob
use
chemiluminesc
probe
detect
nucleic
acid
specifi
c
pathogen
resplex
system
develop
qiagen
use
microarray
technolog
detect
amplifi
ed
speciesspecifi
c
dna
sequenc
sever
organ
biosensor
pcresim
use
mlst
approach
simultan
detect
numer
pathogen
determin
clonal
related
strain
identifi
resist
genotyp
virul
factor
within
hour
one
wide
use
rapid
diagnosi
system
genexpert
system
cepheid
use
realtim
pcr
system
identifi
infect
less
hour
genexpert
system
adapt
identifi
cation
sever
pathogen
includ
methicillinresist
staphylococcu
aureu
mrsa
group
b
streptococcu
clostridium
diffi
cile
tuberculosi
xpert
mtbrif
identifi
es
tuberculosi
use
rpo
b
gene
b
subunit
bacteri
rna
polymeras
rifampicin
resist
marker
mdr
tb
feasibl
effect
system
test
sputum
sampl
individu
persist
cough
week
multipl
centr
six
develop
countri
ie
south
africa
azerbaijan
peru
philippin
india
uganda
tuberculosi
could
detect
less
day
compar
day
requir
liquid
solid
cultur
respect
likewis
time
treatment
smearneg
tuberculosi
reduc
median
day
day
use
mtbrif
assay
interestingli
specifi
citi
sensit
assay
compar
among
centr
countri
differ
capac
indic
mtbrif
system
use
effect
resourcelimit
set
boehm
et
al
genom
research
develop
world
use
rapid
identifi
cation
character
virul
antibiot
resist
diagnosi
emerg
infecti
diseas
necessari
effect
manag
control
epidem
estim
quarter
billion
case
malaria
annual
develop
countri
respons
million
death
annual
approxim
case
occur
south
east
asia
greatest
burden
diseas
africa
malaria
caus
protist
parasit
plasmodium
invad
destroy
erythrocyt
red
blood
cell
detriment
effect
host
parasit
spread
mosquito
vector
anophel
gambia
funestu
plasmodium
falciparum
caus
deadli
form
diseas
diseas
subsaharan
africa
anoth
clinic
signifi
cant
speci
p
vivax
caus
malaria
global
domin
asia
well
south
central
america
p
malaria
p
oval
also
import
caus
malaria
well
et
al
emerg
plasmodium
resist
older
drug
chloroquin
newer
artemisinin
deriv
necessit
research
new
drug
target
whole
genom
sequenc
p
falciparum
p
vivax
fuel
rapid
identifi
cation
character
wide
array
novel
potenti
drug
target
gene
encod
essenti
pathway
parasit
consider
diverg
human
homologu
present
good
target
potenti
drug
identifi
ed
genom
analysi
fosmidomycin
current
phase
ii
clinic
trial
treatment
malaria
fosmidomycin
block
activ
reductoisomeras
involv
nonmevalon
isoprenoid
biosynthesi
pathway
util
plasmodium
absent
human
mammal
isoprenoid
essenti
multifunct
metabolit
involv
cellular
signal
respir
henc
inhibit
synthesi
pathway
kill
p
falciparum
zhang
et
al
potenti
drug
target
identifi
ed
genom
applic
hold
promis
nucleosid
biosynthesi
pathway
dihydroorot
dehydrogenas
gene
occur
apicoplast
absent
human
well
et
al
despit
massiv
diseas
control
intervent
implement
mani
countri
incid
malaria
increas
remain
static
region
africa
amazonia
one
major
challeng
malaria
erad
larg
pool
persist
human
reservoir
infect
endem
region
genomewid
snp
microsatellit
analys
shown
p
falciparum
chronic
infect
character
numer
genet
divers
haploid
parasit
genom
establish
singl
mosquito
bite
multipl
bite
superinfect
high
genet
divers
within
var
gene
encod
major
surfac
antigen
p
falciparum
associ
immun
evas
establish
chronic
superinfect
humantomosquito
transmiss
infect
persist
month
allow
parasit
persist
season
vector
scarc
chen
et
al
comprehens
understand
mechan
immun
evas
virul
import
control
malaria
develop
effect
therapeut
agent
vaccin
strategi
rapid
accur
diagnosi
malaria
critic
save
live
malaria
endem
area
patient
may
present
health
facil
advanc
complic
sever
diseas
rapid
accur
diagnosi
prevent
unnecessari
administr
antimalari
drug
associ
emerg
drug
resist
convent
malaria
diagnosi
develop
world
conduct
light
microscopybas
examin
thick
thin
peripher
blood
smear
howev
techniqu
technic
demand
lowlevel
parasitemia
could
miss
mix
infect
could
misdiagnos
pcrbase
parasit
detect
hold
great
promis
provid
inform
parasit
speci
includ
multipl
infect
load
drug
resist
fairli
quickli
plasmodium
genom
sequenc
avail
highli
conserv
ribosom
rna
rrna
gene
use
molecular
detect
character
malaria
infect
use
nest
pcr
howev
rrna
gene
diverg
copi
may
nontandem
speci
affect
sensit
specifi
citi
gene
target
sever
genom
differ
plasmodium
speci
sequenc
bioinformat
mine
plasmodium
genom
use
identifi
novel
pcr
target
detect
speciat
malaria
shown
great
promis
dema
et
al
human
immunodefi
cienci
viru
hiv
caus
acquir
immun
defi
cienci
syndrom
aid
one
deadliest
import
threat
public
health
economi
global
million
peopl
alreadi
die
aid
last
year
million
peopl
live
hiv
infect
genomicsbas
evolut
studi
suggest
rna
lentiviru
evolv
simian
immunodefi
cienci
viru
siv
transmit
chimpanze
west
central
africa
human
begin
twentieth
centuri
similarli
less
aggress
rel
thought
evolv
siv
infect
sooti
mangabey
west
africa
haagman
et
al
although
infect
wide
distribut
global
infect
show
pattern
restrict
west
africa
perhap
due
lower
transmiss
infect
associ
lower
plasma
viral
load
decreas
rate
mothertochild
transmiss
reduc
aidsrel
mortal
gottlieb
et
al
numer
fulli
sequenc
hiv
genom
great
potenti
compar
genom
could
elucid
molecular
basi
differ
observ
pathogenesi
two
type
hiv
focu
need
place
link
viral
genom
differ
observ
virul
among
hiv
subtyp
studi
subtyp
b
siv
macaqu
model
shown
replic
capac
lentivirus
increas
cours
infect
character
effi
cient
util
chemokin
receptor
increas
replic
capac
virus
late
infect
confer
sequenc
modifi
cation
envelop
segment
etemad
et
al
hiv
research
signifi
cant
focu
hostgenom
factor
infl
uenc
diseas
progress
oppos
pathogengenom
factor
geograph
genet
backgroundassoci
dispar
transmiss
diseas
progress
shown
instanc
nearli
three
quarter
million
hivinfect
peopl
subsaharan
africa
million
south
asia
kaur
mehra
primari
infect
may
progress
rapidli
aid
within
year
among
fast
progressor
howev
among
longterm
nonprogressor
ltnp
diseas
progress
much
slower
ltnp
maintain
low
viral
load
normal
immun
function
decad
anoth
interest
group
individu
repeatedli
highli
expos
remain
seroneg
appear
harbour
natur
resist
fi
nding
put
togeth
suggest
host
factor
modul
immun
evas
viral
entri
replic
may
import
determin
diseas
outcom
fi
rst
hiv
restrict
factor
identifi
ed
delet
allel
cytoplasm
tail
chemokin
receptor
protein
secondari
receptor
lymphocyt
effect
block
infect
homozyg
individu
human
leukocyt
antigen
hla
shown
play
import
role
modul
infecti
diseas
hepat
b
anoth
import
factor
hiv
infect
vannberg
et
al
specifi
calli
certain
snp
hlab
hlac
associ
lower
viral
load
setpoint
reduc
tcell
declin
recent
genomewid
associ
studi
aid
shown
link
snp
hla
region
viral
load
control
among
ltnp
limou
et
al
genomewid
associ
studi
sever
larg
cohort
reveal
least
aid
restrict
gene
involv
regul
viral
cell
entri
cytokin
defenc
acquir
innat
immun
function
kaur
mehra
obrien
nelson
character
host
factor
infl
uenc
suscept
infect
use
platform
identifi
novel
antiretrovir
drug
hiv
much
need
face
frequent
occurr
resist
mutant
recent
haematopoiet
stem
cell
natur
resist
donor
transplant
infect
patient
patient
requir
antiretrovir
treatment
maintain
undetect
viral
load
year
remark
achiev
impact
futur
hiv
control
treatment
hutter
thiel
world
health
organ
defi
ne
diarrhoea
passag
loos
wateri
stool
three
time
daili
blood
stool
could
indic
acut
diarrhoea
dysenteri
approxim
million
death
among
children
less
year
old
attribut
diarrhoea
annual
greatest
burden
diseas
south
asia
africa
mortal
rate
exceed
per
children
develop
world
major
infecti
diarrhoea
pathogen
viral
bacteri
protozoan
primari
mode
transmiss
contamin
drink
water
food
common
caus
infecti
diarrhoea
rotaviru
enterotoxigen
escherichia
coli
howev
shigella
salmonella
camplylobact
yersinia
import
caus
infecti
diarrhoea
global
vibrio
cholera
caus
highli
infecti
epidem
diarrhoea
region
sanit
poor
thapar
sanderson
focu
shigella
bacteri
pathogen
rotaviru
viral
pathogen
rotaviru
belong
reovirida
famili
rna
virus
caus
approxim
diarrhoeal
episod
develop
countri
annual
death
occur
yearli
among
children
africa
asia
genom
studi
shown
human
rotaviru
huge
genet
divers
confer
accumul
mutat
gene
rearrang
frequent
reassort
genom
segment
zoonosi
transmiss
anim
reservoir
rotaviru
also
may
increas
antigen
divers
among
human
strain
mechan
molecular
epidemiolog
studi
shown
circul
genotyp
within
particular
region
chang
time
genotyp
divers
uneven
global
instanc
europ
rotaviru
isol
human
p
genotyp
numer
strain
found
circul
india
greenberg
est
recent
whole
genom
sequenc
two
kenyan
rotaviru
strain
show
sever
gene
distantli
relat
human
strain
prototyp
strain
diverg
gene
kenyan
strain
instead
close
relat
rotaviru
gene
rumin
camelid
origin
fi
nding
signifi
cant
implic
applic
two
current
licens
rotaviru
vaccin
rotateq
merck
rotarix
glaxosmithklin
excel
protect
effi
caci
highincom
countri
unequ
effi
caci
develop
countri
schaetti
futur
vaccin
develop
probabl
reli
extens
genom
studi
identifi
vaccin
target
broader
specifi
citi
identifi
cation
regionspecifi
c
protect
target
burden
bacillari
dysenteri
primarili
caus
shigella
highest
develop
world
among
children
fi
shigella
caus
gramneg
bacterium
infect
highli
contagi
less
bacteria
requir
caus
infect
surprisingli
estim
million
case
million
death
associ
pathogen
annual
invas
colon
mucosa
shigella
result
infl
ammat
ulcer
bleed
pregenom
era
nonmotil
shigella
intracellular
pathogen
regard
distinct
genu
e
coli
extracellular
pathogen
howev
phylogenet
studi
base
type
housekeep
gene
dna
hybrid
wholegenom
sequenc
show
shigella
speci
variou
subtyp
taxonom
indistinguish
e
coli
peng
et
al
shigella
speci
evolv
e
coli
multipl
distinct
occas
may
explain
larg
genom
divers
antigen
variabl
complex
classifi
cation
molecular
analysi
reveal
presenc
larg
virul
plasmid
encod
type
iii
secret
system
tti
key
regulatori
gene
associ
shigella
pathogenesi
nich
ie
human
colon
mucosa
specifi
c
adapt
peng
et
al
whole
genom
sequenc
sever
shigella
subtyp
shown
bacteria
larg
sequenc
overlap
e
coli
almost
backbon
open
read
frame
orf
genom
research
provid
unpreced
capac
develop
novel
vaccin
strategi
identifi
specifi
c
drug
target
backbon
orf
gene
encod
essenti
signal
metabol
regulatori
pathway
although
aetiolog
pathogenesi
infecti
diarrhoea
well
character
molecular
diagnost
remain
dark
area
recent
larg
number
possibl
aetiolog
agent
repres
divers
organ
rang
viral
bacteri
protozoan
complic
accur
identifi
cation
caus
pathogen
thu
administr
appropri
treatment
furthermor
pathogen
e
coli
campylobact
salmonella
may
found
gastrointestin
mucosa
asymptomat
individu
honey
diagnosi
particularli
problemat
resourcelimit
set
pathogen
identifi
cation
primarili
base
convent
laboratori
cultur
stool
sampl
typic
requir
least
h
bacteri
pathogen
discrimin
pathogen
nonpathogen
e
coli
speci
last
year
diagnost
test
infecti
diarrhoea
becom
avail
mostli
base
amplifi
cation
specifi
c
nucleotid
sequenc
alon
combin
microarray
analysi
highresolut
melt
analys
multipl
infect
identifi
ed
accur
pathogen
load
associ
diseas
determin
molecular
identifi
cation
assay
use
differenti
pathogen
morpholog
biochem
indistinguish
shiga
toxinproduc
enteropathogen
strain
e
coli
avirul
strain
bugarel
et
al
import
protozoan
pathogen
diffi
cult
cultur
entamoeba
histolytica
cryptosporidium
giardia
identifi
ed
use
molecular
techniqu
target
specifi
c
gene
preval
pathogen
gastrointestin
mucosa
confi
rmed
larg
molecular
epidemiolog
studi
bangladesh
haqu
et
al
recent
studi
use
metagenom
approach
identifi
known
diarrhoeal
agent
discov
novel
potenti
viral
pathogen
stool
sampl
paediatr
patient
suffer
acut
diarrhoea
finkbein
et
al
identifi
cation
new
pathogen
particularli
import
aetiolog
agent
never
found
mani
diarrhoea
case
metagenom
discuss
detail
follow
section
although
current
metagenom
applic
may
still
inaccess
mani
part
develop
world
limit
resourc
data
gener
kind
studi
could
adapt
cheaper
access
applic
diagnosi
infecti
diarrhoea
neglect
tropic
diseas
ntd
cover
wide
spectrum
old
emerg
diseas
caus
helminth
protozoa
fungi
bacteria
viral
pathogen
togeth
infect
estim
one
billion
peopl
receiv
rel
littl
attent
warrant
name
neglect
half
peopl
infect
ntd
subsaharan
africa
ntd
tend
occur
poorest
remot
disadvantag
region
world
disabl
disfi
gure
often
time
fatal
pathogenesi
transmiss
epidemiolog
mani
pathogen
poorli
understood
lack
appropri
diagnost
tool
likewis
licens
vaccin
ntd
mani
avail
drug
optim
effect
ineffect
ntd
infect
henc
great
potenti
genom
uncov
virul
factor
molecular
epidemiolog
genom
organ
potenti
drug
vaccin
target
ntd
trypanosomiasi
refer
sever
distinct
diseas
caus
protozoan
parasit
trypanosom
human
african
trypanosomiasi
hat
lifethreaten
infect
caus
trypanosoma
brucei
gambiens
trypanosoma
brucei
rhodesiens
infect
peopl
subsaharan
africa
latin
america
trypanosom
caus
chaga
diseas
import
caus
morbid
mortal
region
sequenc
trypanosom
genom
made
remark
contribut
understand
parasit
pathogenesi
hostparasit
interact
mechan
genet
exchang
diseas
diagnosi
molecular
epidemiolog
drug
mechan
action
tait
et
al
zucca
savoia
current
hat
treatment
regimen
highli
toxic
requir
prolong
period
administr
monitor
problemat
resourcelimit
set
diseas
burden
greatest
henc
need
identifi
cation
new
drug
target
could
expedit
structur
compar
genom
promis
target
new
drug
treatment
chaga
diseas
alreadi
identifi
ed
use
genom
proteom
approach
eg
drug
target
trypanosom
purin
salvag
pathway
cruzipain
cystein
proteas
ergosterol
trypanothion
biosynthesi
investig
mckerrow
et
al
tuberculosi
mycobacteria
also
caus
buruli
ulcer
leprosi
disabl
disfi
gure
diseas
infect
thousand
peopl
develop
countri
buruli
ulcer
emerg
diseas
subcutan
tissu
caus
mycobacterium
ulceran
slowgrow
pathogen
ulceran
close
relat
mycobacterium
marinum
caus
mild
skin
infect
human
howev
compar
genom
studi
progenitor
marinum
shown
ulceran
larg
delet
approxim
mb
genom
acquir
virul
plasmid
confer
mycolacton
product
horizont
gene
transfer
reduc
genom
size
ulceran
associ
loss
sever
virul
factor
present
marinum
acquisit
immunosuppress
cytotoxin
make
nicheadapt
specialist
demangel
et
al
case
ulceran
highlight
evolutionari
genom
use
understand
pathogenesi
emerg
infect
identifi
cation
key
virul
factor
set
stage
futur
studi
target
vaccin
develop
lead
caus
infecti
blind
global
trachoma
million
case
activ
diseas
around
trachoma
diseas
burden
global
concentr
ten
develop
countri
trachoma
caus
oblig
intracellular
pathogen
chlamydia
trachomati
also
lead
caus
sexual
transmit
infect
result
immens
loss
product
repres
major
public
health
socioeconom
burden
need
effect
trachoma
vaccin
greater
ever
current
avail
antimicrobi
treatment
prevent
reinfect
c
trachomati
easili
transmit
asymptomat
carrier
establish
new
infect
chlamydi
genom
research
reveal
sever
protect
antigen
epitop
could
appli
effect
vaccin
eko
et
al
metagenom
refer
collect
cultureindepend
function
andor
sequencebas
studi
microbi
genom
term
metagenom
contain
anim
host
plant
environment
nich
handelsman
et
al
recent
major
advanc
nextgener
dnasequenc
tool
capac
handl
mega
metadata
set
previous
unimagin
increas
appreci
import
complex
microbi
commun
health
diseas
brought
metagenom
approach
forefront
molecular
microbiolog
microbi
ecolog
mucos
surfac
common
site
microbi
colon
infect
mucosa
respiratori
digest
tract
urogenit
tract
eye
conjunctiva
inner
ear
exocrin
gland
duct
togeth
provid
surfac
area
kunisawa
et
al
term
human
microbiom
describ
microbi
commun
compon
colon
human
bodi
includ
skin
mucos
surfac
petrosino
et
al
hostmicrob
interact
key
compon
normal
human
physiolog
essenti
regul
infl
ammatori
respons
develop
immun
system
metabol
function
nutrient
process
uptak
storag
inhibit
pathogen
kelli
conway
henc
microbiom
play
import
role
diseas
also
mainten
health
enhanc
complement
host
physiolog
phenotyp
handelsman
metagenom
tool
use
show
associ
microbiom
sever
diseas
nec
atop
eczema
obes
cd
copd
cystic
fi
brosi
type
ii
diabet
oral
cancer
bacteri
vaginosi
periodont
diseas
among
mani
other
peterson
et
al
diseas
associ
disrupt
chang
normal
microbi
ecolog
also
evid
infect
polymicrobi
one
microb
act
synergist
sequenti
caus
infect
endogen
microbi
interact
diseas
develop
well
illustr
pathogenesi
burkitt
lymphoma
xdrtb
burkitt
lymphoma
childhood
cancer
character
prolifer
monoclon
bcell
endogen
interact
malaria
pathogen
p
falciparum
epsteinbarr
viru
believ
give
rise
bcell
lymphoma
impair
immun
surveil
rochford
et
al
xdrtb
emerg
pathogen
primarili
coinfect
peopl
advanc
stage
hiv
infect
goldman
et
al
although
limit
data
avail
report
suggest
genom
function
constitut
pharyng
microbiom
markedli
vari
geograph
pathogen
genom
potenti
understand
locat
nasopharynx
particular
import
reservoir
commens
pathogen
microb
migrat
caus
diseas
compart
sinu
middl
ear
lung
blood
buchanan
et
al
invas
bacteri
diseas
ibd
pneumonia
mening
bacteraemia
caus
pathogen
colon
nasopharynx
contribut
dispar
childhood
mortal
develop
develop
countri
rrna
genebas
termin
restrict
fragment
length
polymorph
trflp
conjunct
clone
librari
sequenc
use
character
develop
nasopharyng
microbiom
among
infant
highrisk
popul
west
africa
studi
show
infant
cocolon
multipl
oper
taxonom
unit
otu
repres
pathogen
speci
pneumonia
haemophilu
infl
uenza
moraxella
catarrhali
aureu
small
proport
infant
rare
harbour
otu
fi
nding
confi
rmed
pcr
analysi
hypothes
structur
composit
microbiom
may
associ
high
rate
ibd
caus
respiratori
pathogen
observ
among
infant
popul
studi
compar
infant
nasopharyng
microbiom
differ
geograph
site
among
distinct
popul
need
understand
link
microbiom
risk
ibd
signifi
canc
human
microbiom
relat
health
diseas
come
forefront
microbiolog
sever
hundr
million
pour
multicentr
intern
project
initi
last
decad
notabl
nation
institut
health
nih
human
microbiom
project
hmp
metagenom
studi
look
differ
mucos
surfac
among
variou
region
develop
world
enhanc
understand
prevent
diseas
also
maintain
health
still
licens
vaccin
avail
sever
import
pathogen
aureu
shigella
moraxella
catarrhali
hiv
p
falciparum
wide
avail
vaccin
bcg
tb
optim
effect
licens
pneumococc
conjug
vaccin
pcv
limit
valenc
protect
serotyp
exclud
mani
clinic
signifi
cant
serotyp
develop
countri
henc
great
potenti
vaccin
drug
discoveri
unpreced
speed
develop
world
novel
bacteri
antigen
subunit
vaccin
could
identifi
ed
predict
gene
encod
potenti
surfaceloc
protein
sequenc
genom
clone
identifi
ed
gene
express
protein
test
immunogen
vivo
vitro
appli
identifi
cation
potenti
vaccin
target
n
meningitidi
serogroup
b
porphyromona
gingivali
pneumonia
chlamydophila
pneumonia
pasteurella
multocida
antigen
identifi
ed
whole
genom
sequenc
enter
develop
clinic
phase
numer
genom
differ
strain
pathogen
speci
rapidli
becom
avail
public
databas
highli
conserv
univers
antigen
identifi
ed
inclus
vaccin
formul
potenti
vaccin
target
also
identifi
ed
target
search
specifi
c
antigen
within
sequenc
genom
instanc
piluslik
structur
initi
identifi
ed
corynebacterium
diphtheria
shown
good
vaccin
candid
gb
henc
research
search
similar
gene
close
relat
group
streptococcu
ga
streptococcu
pneumonia
genom
mora
telford
formul
includ
multipl
piluslik
structur
potenti
vaccin
candid
widecoverag
gramposit
organ
although
still
infanc
genom
applic
vaccin
develop
may
shorten
time
identifi
novel
antigen
newgener
vaccin
compar
virulencebas
approach
sinc
numer
antimicrobi
discov
natur
sourc
develop
synthet
revolution
medicin
massiv
impact
morbid
mortal
howev
last
year
pathogen
emerg
barrag
defenc
import
antibiot
rais
seriou
public
health
concern
develop
develop
countri
pathogen
includ
xdrmdr
tb
mrsa
vancomycinresist
enterococcu
pseudomona
aeruginosa
extendedspectrum
b
lactamaseproduc
enterobacteriacea
henc
need
develop
new
drug
treatment
strategi
prevent
colon
furthermor
still
effect
antimicrobi
agent
effect
viral
pathogen
brotzoesterhelt
sass
genom
approach
use
discov
new
drug
two
major
pathway
screen
genom
microb
natur
produc
antibiot
actinomycet
bioactiv
compound
therapeut
potenti
davi
screen
pathogen
genom
highli
conserv
univers
pathway
could
potenti
drug
target
potenti
drug
target
also
need
essenti
bacteri
surviv
nutrientrich
environ
host
target
pathogen
must
mechan
circumv
target
pathway
one
exampl
potenti
drug
discov
largescal
genom
screen
fatti
acid
biosynthesi
inhibitor
seri
target
fabi
enoylacyl
carrier
protein
acp
reductas
enter
clinic
trial
treatment
aureu
oral
infect
brotzoesterhelt
sass
although
rel
littl
success
novel
antimicrobi
drug
discoveri
genom
era
genom
tool
still
hold
great
promis
futur
endeavour
particularli
develop
world
theoret
could
possibl
identifi
antimicrobi
antimicrobi
target
uncultur
organ
metagenom
approach
target
biosynthet
pathway
could
use
screen
complex
microbi
popul
howev
cuttingedg
well
simpler
genomicsderiv
applic
could
use
point
care
bedsid
particularli
diagnost
molecular
diagnost
frontier
genom
develop
world
rapid
access
assay
use
minim
resourc
whole
genom
sequenc
technolog
rapidli
becom
cheaper
access
faster
henc
quit
possibl
futur
diagnost
could
employ
whole
genom
sequenc
particularli
emerg
infect
cultureneg
infect
molecular
probe
may
avail
variat
genom
repres
marker
gene
oligonucleotid
bind
site
polymorph
low
depth
sampl
may
overcom
whole
genom
sequenc
sequenc
microbi
genom
tool
provid
comprehens
taxonom
phylogenet
inform
pathogen
also
function
biochem
metabol
properti
petrosino
et
al
whole
genom
amplifi
cation
wga
base
polymerasemedi
multipl
displac
amplifi
cation
develop
gener
billionfold
amplifi
cation
dna
femtogram
amount
even
singl
microbi
cell
siegl
et
al
howev
annot
genom
huge
comput
demand
analysi
taxonom
group
without
previous
sequenc
genom
major
challeng
although
still
develop
wga
singlecel
genom
hold
great
promis
investig
rapid
detail
diagnost
test
develop
world
comprehens
character
pangenom
microbi
evolut
popul
structur
signifi
cant
implic
design
vaccin
treatment
strategi
pathogen
petrosino
et
al
rapid
molecular
diagnosi
infect
import
sever
reason
time
administr
appropri
treatment
determin
drug
resist
earli
manag
control
highli
infecti
ill
prevent
epidem
prevent
dropout
losstofollowup
prolong
diagnost
period
highthroughput
gener
molecular
epidemiolog
data
detail
genotyp
pathogen
possibl
clinic
specimen
analys
real
time
use
autom
system
requir
littl
handson
time
henc
effect
applic
genom
applic
huge
potenti
reduc
morbid
mortal
associ
misdiagnosi
delay
diagnosi
nonetheless
system
describ
yet
wide
access
develop
world
technolog
resourc
capac
often
avail
henc
collabor
develop
countri
access
fund
inform
exchang
need
expand
support
implement
system
develop
world
emerg
infecti
diseas
among
import
threat
public
health
global
economi
signifi
cant
increas
rate
emerg
infecti
diseas
last
year
partli
attribut
hiv
pandem
approxim
zoonot
aris
wildlif
eg
ebola
viru
genom
tool
develop
rapid
identifi
cation
classifi
cation
diagnosi
treatment
emerg
reemerg
microbi
pathogen
viral
agent
devast
sar
coronaviru
rapidli
identifi
ed
employ
molecular
virolog
immunolog
epidemiolog
techniqu
sever
acut
respiratori
syndrom
coronaviru
sarscov
entir
genom
sequenc
shortli
emerg
southern
china
compar
genom
use
confi
rm
natur
reservoir
civet
cat
contribut
effect
control
epidem
haagman
et
al
genom
analys
identifi
ed
uncultur
bacteria
tropheryma
whipplei
bartonella
hensela
caus
agent
whippl
diseas
bacillari
angiomatosi
respect
develop
countri
tropic
highest
rel
risk
emerg
infecti
diseas
zoonot
pathogen
wildlif
reservoir
vectorborn
pathogen
henc
vigil
surveil
effort
strengthen
region
pathogen
cross
speci
barrier
genom
studi
use
identifi
cation
genet
chang
enabl
pathogen
interact
differ
receptor
establish
infect
new
host
speci
compar
genom
sarscov
civet
human
outbreak
china
show
sar
genom
highli
conserv
virus
two
host
genom
analys
also
demonstr
high
genet
divers
sever
critic
gene
particularli
spike
gene
sarscov
civet
play
key
role
increas
civettohuman
humantohuman
transmiss
viru
likewis
genom
studi
demonstr
genet
variabl
haemagglutinin
molecul
enabl
infl
uenza
viru
switch
receptor
host
specifi
citi
instanc
mammalian
infl
uenza
virus
preferenti
bind
oligosaccharid
termin
sialic
acida
avian
infl
uenza
favour
sialic
acida
disaccharid
produc
human
lower
respiratori
tract
cell
haagman
et
al
exampl
highlight
pathogengenom
studi
util
understand
mechan
pathogen
employ
increas
transmiss
cross
speci
barrier
emerg
infecti
diseas
zoonot
mani
origin
develop
world
genom
appli
elucid
genet
properti
system
enhanc
transmiss
pathogen
instanc
abil
persist
popul
rel
long
period
time
may
boost
transmiss
pathogen
individu
sever
contact
way
enhanc
transmiss
includ
capac
cross
speci
barrier
adapt
new
host
eg
migratori
bird
surviv
harsh
environ
radiat
nutrient
depriv
high
immun
pressur
adher
wide
rang
host
cell
type
jone
et
al
genom
use
epidemiolog
character
known
virul
factor
discoveri
novel
virul
factor
whole
genom
sequenc
conduct
numer
microbi
speci
shown
consider
variat
size
content
organ
genom
pathogen
may
associ
metabol
versatil
virul
invalu
understand
diseas
develop
world
host
pathogen
genom
provid
invalu
insight
factor
infl
uenc
heterogen
seen
transmiss
vulner
infect
diseas
progress
diseas
outcom
among
individu
differ
age
strata
ethnic
socioeconom
background
geograph
region
expos
pathogen
microb
inform
better
diseas
control
manag
strategi
mani
genom
tool
wide
access
develop
world
foster
intern
collabor
becom
increasingli
import
furthermor
fund
foster
intern
collabor
build
capac
within
resourcelimit
set
develop
rapid
cheap
sustain
techniqu
use
develop
world
urgent
need
